Status:
WITHDRAWN
Portal Vein Thrombosis in Cirrhosis
Lead Sponsor:
Corporacion Parc Tauli
Conditions:
Hepatic Vein Thrombosis
Cirrhosis
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the supervivence of cirrhotic patients that develop portal vein thrombosis in comparison to cirrhotic patients that do not develop portal vein thrombosis.
Detailed Description
Patients newly diagnosed with portal vein thrombosis by imaging tests, that evaluate the extent and exclude tumoral origin, will be included (informed consent previously signed). Anticoagulant treatm...
Eligibility Criteria
Inclusion
- Cirrhosis diagnosed by liver biopsy or non-invasive methods/clinical, analytics or ultrasound usual criteria
- Portal vein thrombosis of newly diagnosed (defined as partial or complete obstruction of splenoportal vessels objectified by imaging with/without symptomatology) ≤ 6 months.
- Over 18 years old
- Want to participate (informed consent)
Exclusion
- Pregnant or lactating
- Patients with tumoral vein thrombosis or elevated alpha-fetoprotein or high suspicion of underlying neoplastic disease.
- Thrombocytopenia \< 25.000 .
- Patients with cavernomatosis or portal vein thrombosis already known.
- Patient refusal to participate
- Patients already treated with anticoagulants for other diseases (atrial fibrillation, pulmonary thrombosis...)
Key Trial Info
Start Date :
October 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02275585
Start Date
October 1 2013
End Date
October 1 2014
Last Update
August 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.